
Livzon Pharmaceutical Group
Asia, Guangdong, China, Zhuhai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Livzon is a comprehensive pharmaceutical enterprise integrating development & research, production and sales of pharmaceutical products.
Investor Profile
Livzon Pharmaceutical Group has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 25% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Medical, Health Care.
Stage Focus
- Series B (75%)
- Series C (25%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Medical
- Health Care
- Life Science
- Therapeutics
- Artificial Intelligence (Ai)
- Health Diagnostics
- Machine Learning
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.